Surgical alternatives to transplantation and assist devices in the treatment of heart failure

被引：4

作者：

DeRose Jr. J.J. ^{[1
]}

Oz M.C. ^{[1
]}

机构：

[1] Division of Cardiothoracic Surgery, Columbia University College of Physicians and Surgeons, Milstein Hospital Building, New York, NY 10032

来源：

Current Cardiology Reports | 2000年 / 2卷 / 6期

关键词：

Mitral Valve; Coronary Artery Bypass Grafting; Mitral Regurgitation; Left Ventricular Assist Device; Mitral Valve Repair;

D O I：

10.1007/s11886-000-0043-0

中图分类号：

学科分类号：

摘要：

It is estimated that in the United States 30,000 patients with end-stage heart disease are eligible for heart transplantation, although less than 2500 are actually performed each year. As the population ages, several thousand other patients who are ineligible for cardiac transplantation will be left with limited options. Surgical strategies aimed at halting the progression of heart failure have therefore been devised. High-risk coronary artery bypass grafting can improve ejection fraction and alleviate heart failure symptoms in appropriately selected patients. Mitral valve repair and ventricular aneurysm resection/plication procedures may improve heart failure by decreasing the volume load on the left ventricle. Myoreduction operations (Batista operation) aim to improve the volume and wall stress relationship of the dilated left ventricle, but their clinical application has remained experimental. Copyright © 2000 by Current Science Inc.

引用

页码：564 / 571

页数：7

共 45 条

[1]

Coronary artery surgery study (CASS): A randomized trial of coronary artery bypass surgery, Survival Data. Circulation, 68, pp. 939-950, (1983)

[2]

Wijns W., Vatner S., Camici P.G., Hibernating myocardium, N Engl J Med, 339, pp. 173-181, (1998)

[3]

Arnese M., Cornel J., Salustri A., Et al., Prediction of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201-T1 single photon emission computed tomography, Circulation, 91, pp. 2748-2752, (1995)

[4]

Rkm C., Raman J., Lee K.J., Et al., Prediction of outcome after revascularization with poor left ventricular function, Ann Thorac Surg, 61, pp. 1428-1434, (1996)

[5]

Pagano D., Townend J., Horton R., Et al., Coronary artery bypass grafting for ischemic heart failure. The predictive value of quantitative PET for symptomatic and functional outcome, J Thorac Cardiovasc Surg, 115, pp. 791-799, (1998)

[6]

Bonow R., Identification of viable myocardium, Circulation, 94, pp. 2674-2678, (1996)

[7]

Meluzin J., Cerny J., Frelich M., Et al., Prognostic value of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction, J Am Coll Cardiol, 32, pp. 912-920, (1998)

[8]

Anderson W.A., Ilkowski D.A., Mahan V.L., Et al., Coronary artery bypass grafting in patients with chronic congestive heart failure: A 10-year experience with 203 patients, J Cardiac Surg, 12, pp. 167-175, (1997)

[9]

Elefteriades J.A., Dls M., Gradel C., Et al., Results of coronary artery bypass grafting by a single surgeon in patients with left ventricular ejection fractions < 30%, Am J Cardiol, 79, pp. 1573-1578, (1997)

[10]

Mickelborough L.L., Carson S., Tamariz M., Ivanov J., Results of revascularization in patients with severe left ventricular dysfunction, J Thorac Cardiovasc Surg, 19, pp. 550-557, (2000)

← 1 2 3 4 5 →